CAPN10
CAPN10 (calpain 10) is an atypical member of the calpain family of calcium-dependent cysteine proteases. It catalyses limited proteolysis of substrates involved in cytoskeletal remodelling and signal transduction, and the CAPN10 gene is associated with type 2 diabetes mellitus. Browse Assay Genie's current range of CAPN10 research reagents below, or read on for the biology behind the target.
CAPN10 is a calcium-regulated, non-lysosomal thiol-protease that catalyses limited proteolysis of substrates involved in cytoskeletal remodelling and signal transduction. UniProt also notes that it may play a role in insulin-stimulated glucose uptake. It belongs to the peptidase C2 family.
Calpains are a ubiquitous, well-conserved family of calcium-dependent cysteine proteases. Classical calpains are heterodimers of an invariant small subunit and a variable large subunit. The large catalytic subunit has four domains: domain I, an N-terminal regulatory domain that is processed on activation; domain II, the protease domain; domain III, a linker domain of unknown function; and domain IV, a calmodulin-like calcium-binding domain. The CAPN10 gene encodes a large subunit. It is atypical because it lacks the calmodulin-like calcium-binding domain and instead has a divergent C-terminal domain. Its organisation is similar to that of calpains 5 and 6. Multiple alternative transcript variants have been described for the CAPN10 gene.
HGNC places the gene in the calpains group. The CAPN10 gene is associated with type 2 or non-insulin-dependent diabetes mellitus (NIDDM) and lies within the NIDDM1 region, which makes the protein a recurring subject in studies of glucose metabolism. Mouse and rat orthologs, both named Capn10, are recorded.
The CAPN10 gene is associated with type 2 diabetes mellitus and sits within the NIDDM1 region, making it a genetic focus in diabetes studies.
CAPN10 may play a role in insulin-stimulated glucose uptake, so it is studied in insulin signalling and glucose handling.
Calpain-10 catalyses limited proteolysis of substrates involved in cytoskeletal remodelling, relevant to work on how proteolysis shapes cell structure.
As an atypical calpain lacking the calmodulin-like calcium-binding domain, CAPN10 is used to compare domain organisation and regulation across the family.
CAPN10 is a calcium-regulated, non-lysosomal thiol-protease. It catalyses limited proteolysis of substrates involved in cytoskeletal remodelling and signal transduction, and UniProt notes it may play a role in insulin-stimulated glucose uptake. It belongs to the peptidase C2 family.
The HGNC name is calpain 10, and UniProt lists the protein as Calpain-10. No alternative symbols are recorded. NCBI Gene reports that multiple alternative transcript variants have been described for this gene, so check which variant a reagent targets.
The CAPN10 gene is associated with type 2 (non-insulin-dependent) diabetes mellitus and lies within the NIDDM1 region. Orthologs named Capn10 exist in mouse and rat; check the datasheet of any product for its validated reactivity.
Other calpain family members, including CAPN5 and CAPN6, which share a similar organisation, and the calpain small subunit.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9HC96; product specifications from Assay Genie datasheets.